The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hypoprothrombinemias


High impact information on Hypoprothrombinemias


Chemical compound and disease context of Hypoprothrombinemias


Biological context of Hypoprothrombinemias


Gene context of Hypoprothrombinemias


  1. Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism. Self, T., Weisburst, M., Wooten, E., Straughn, A., Oliver, J. JAMA (1975) [Pubmed]
  2. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans. O'Reilly, R.A., Motley, C.H. Ann. Intern. Med. (1979) [Pubmed]
  3. Severe hemorrhage in a patient with circulating anticoagulant, acquired hypoprothrombinemia, and systemic lupus erythematosus. Small, P. Arthritis Rheum. (1988) [Pubmed]
  4. Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections. Nichols, R.L., Wikler, M.A., McDevitt, J.T., Lentnek, A.L., Hosutt, J.A. Antimicrob. Agents Chemother. (1987) [Pubmed]
  5. Patterns of bleeding after endoscopic sphincterotomy, the subsequent risk of bleeding, and the role of epinephrine injection. Wilcox, C.M., Canakis, J., Mönkemüller, K.E., Bondora, A.W., Geels, W. Am. J. Gastroenterol. (2004) [Pubmed]
  6. The stereoselective interaction of warfarin and metronidazole in man. O'Reilly, R.A. N. Engl. J. Med. (1976) [Pubmed]
  7. Cefotetan and hypoprothrombinemia. Conjura, A., Bell, W., Lipsky, J.J. Ann. Intern. Med. (1988) [Pubmed]
  8. Potential for bleeding with the new beta-lactam antibiotics. Sattler, F.R., Weitekamp, M.R., Ballard, J.O. Ann. Intern. Med. (1986) [Pubmed]
  9. Hypoprothrombinemia and bleeding due to cefoperazone. Osborne, J.C. Ann. Intern. Med. (1985) [Pubmed]
  10. Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics. Lipsky, J.J. Proc. Natl. Acad. Sci. U.S.A. (1984) [Pubmed]
  11. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man. O'Reilly, R.A. Circulation (1982) [Pubmed]
  12. Hypoprothrombinemia associated with cefamandole use in a rural teaching hospital. Bertino, J.S., Kozak, A.J., Reese, R.E., Chiarello, L.A. Arch. Intern. Med. (1986) [Pubmed]
  13. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man. O'Reilly, R.A. Arch. Intern. Med. (1984) [Pubmed]
  14. Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillin. Jones, P.G., Strother, S.V., Rolston, K.V., Fainstein, V., Bodey, G.P. Arch. Intern. Med. (1986) [Pubmed]
  15. O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone. Sakaeda, T., Kakushi, H., Shike, T., Takano, K., Harauchi, T., Hirata, M., Hirano, K. Journal of drug targeting. (1998) [Pubmed]
  16. Decreased hypoprothrombinemic effect of warfarin associated with furosemide. Laizure, S.C., Madlock, L., Cyr, M., Self, T. Therapeutic drug monitoring. (1997) [Pubmed]
  17. Cefazolin administration and 2-methyl-1,3,4-thiadiazole-5-thiol in human tissue: possible relationship to hypoprothrombinemia. Wood, T.C., Johnson, K.L., Naylor, S., Weinshilboum, R.M. Drug Metab. Dispos. (2002) [Pubmed]
  18. Changes in some hemostatic parameters in patients with infections treated with ceftazidime and latamoxef. Gabryelewicz, A., Prokopowicz, J., Wołosowicz, N., Czajkowski, A., Dabrowska, M. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. (1987) [Pubmed]
  19. Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia. Linder, J.D., Mönkemüller, K.E., Davis, J.V., Wilcox, C.M. South. Med. J. (2000) [Pubmed]
  20. The warfarin-sulfinpyrazone interaction: stereochemical considerations. Toon, S., Low, L.K., Gibaldi, M., Trager, W.F., O'Reilly, R.A., Motley, C.H., Goulart, D.A. Clin. Pharmacol. Ther. (1986) [Pubmed]
  21. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Akhavan, S., Mannucci, P.M., Lak, M., Mancuso, G., Mazzucconi, M.G., Rocino, A., Jenkins, P.V., Perkins, S.J. Thromb. Haemost. (2000) [Pubmed]
  22. Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin. Van Steenbergen, W., Vermylen, J. Am. J. Gastroenterol. (1995) [Pubmed]
WikiGenes - Universities